![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinigengroup.com/news/news-container/2021/removal-of-erwinase-crisantaspase-supply-constraints-in-the-united-kingdom/?utm_medium=landing%20page&utm_source=Act-On%20Software&utm_campaign=UK%20Supply%20Problem%20Newsletter%20-%20November&utm_content=landing%20page
https://en.prnasia.com/releases/global/porton-biologics-announces-closing-series-a-financing-to-drive-commercial-production-of-gene-and-cell-therapy-315498.shtml
http://www.pharmafile.com/news/531738/porton-biopharma-signs-potential-24m-deal-push-its-intranasal-anthrax-vaccine-phase-1-tr